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Abstract
Background: Intra-fraction motion represents a crucial issue in the era of precise radiotherapy in several settings,
including breast irradiation. To date, only few data exist on real-time measured intra-fraction motion in breast
cancer patients. Continuous surface imaging using visible light offers the capability to monitor patient movements
in three-dimensional space without any additional radiation exposure. The aim of the present study was to quantify
the uncertainties of possible intra-fractional motion during breast radiotherapy.
Material and methods: One hundred and four consecutive patients that underwent postoperative radiotherapy
following breast conserving surgery or mastectomy were prospectively evaluated during 2028 treatment sessions.
During each treatment session the patients’ motion was continuously measured using the Catalyst™ optical surface
scanner (C-RAD AB, Sweden) and compared to a reference scan acquired at the beginning of each session. The
Catalyst system works through an optical surface imaging with light emitting diode (LED) light and reprojection
captured by a charge coupled device (CCD) camera, which provide target position control during treatment
delivery with a motion detection accuracy of 0.5 mm. For 3D surface reconstruction, the system uses a non-rigid
body algorithm to calculate the distance between the surface and the isocentre and using the principle of optical
triangulation. Three-dimensional deviations and relative position differences during the whole treatment fraction
were calculated by the system and analyzed statistically.
Results: Overall, the maximum magnitude of the deviation vector showed a mean change of 1.93 mm ± 1.14 mm
(standard deviation [SD]) (95%-confidence interval: [0.48–4.65] mm) and a median change of 1.63 mm during dose
application (beam-on time only). Along the lateral and longitudinal axis changes were quite similar (0.18 mm± 1.06 mm
vs. 0.17 mm± 1.32 mm), on the vertical axis the mean change was 0.68 mm± 1.53 mm. The mean treatment session
time was 154 ± 53 (SD) seconds and the mean beam-on time only was 55 ± 16 s. According to Friedman’s test
differences in the distributions of the three possible directions (lateral, longitudinal and vertical) were significant
(p < 0.01), in post-hoc analysis there were no similarities between any two of the three directions.
Conclusion: The optical surface imaging system is an accurate and easy tool for real-time motion management in breast
cancer radiotherapy. Intra-fraction motion was reported within five millimeters in all directions. Thus, intra-fraction motion
in our series of 2028 treatment sessions seems to be of minor clinical relevance in postoperative radiotherapy of breast
cancer.
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Background
Over the last decade, modern radiotherapy (RT) tech-
niques including intensity modulated radiation therapy
(IMRT), volumetric-modulated arc therapy (VMAT) or
hypofractionated radiotherapy regimens have been intro-
duced in breast cancer irradiation. These technological
and technical improvements in RT require an accurate
and reliable patient positioning. [1] Inter-fractional vari-
abilities in patient positioning are typically handled by
X-ray images acquired with electronic portal imaging de-
vices (EPID) before a treatment session additional to
laser-assisted positioning. As a consequence patients are
exposed to additional ionizing radiation. [2–4]
Patient movements during breast cancer radiotherapy
and especially during dose delivery have been limited in
scope in clinical context, although it might have an im-
pact on adequate planning target volume (PTV) setup
margins.[5, 6] Nowadays, optical surface imaging offers
the possibility to monitor patient movements in
real-time using a non-invasive approach without any
additional radiation exposure. The system offers a con-
crete option for safe patient positioning and has been ana-
lyzed by several study groups. [7–9] Crop et al. showed
that the optical system Catalyst™ was superior to
laser-assisted positioning. In addition, Stieler et al. re-
ported a reduction in cone beam computed tomography
(CBCT) scans needed in patients with a fixed tumour to
the surface relationship.[10, 11] In regard to intra-frac-
tional motion, Ricotti et al. recently reported results from
breast cancer RT using an infrared light system with sur-
face skin markers. The mean baseline drift was 0 ±
0.7 mm in right-left, − 0.5 ± 1.7 mm in inferior-superior
and − 1.4 ± 1.8 mm in posterior-anterior direction. [12]
Furthermore, Gaisberger et al. used 3D body surface im-
aging and noticed intrafractional shifts of 1.2 ± 0.7 mm
during the first 2 min of observation. [13]
The aim of the present study was to quantify the
uncertainties of possible intra-fractional chest motion
during breast radiotherapy by using the real-time optical
surface imaging system Catalyst™.
Methods
Between October, 2016 and June, 2017, 104 women di-
agnosed with breast cancer, who received postoperative
RT at the Department of Radiation Oncology, University
Hospital, LMU Munich were consecutively recruited in
a prospective study. RT-related information, tumour and
patient characteristics of each patient were retrieved
from medical records. The conventional fractionated RT
scheme to the breast or chest wall was 2Gy to a total
dose of 50Gy in 25 fractions, a sequential boost to the
tumour bed was applied with a dose of 5× 2Gy or 8×
2Gy. Hypofractionated treatments were applied with a
dose of 2.67Gy per fraction to a total dose of 40Gy.
Patients who received RT in deep inspiration breath
hold (DIBH) were excluded from the present ana-
lysis.[14, 15] The study was approved by the local ethics
committee of the University Hospital, LMU Munich
(No. 352–16 ex 09/2016) and registered at German
Clinical Trials Register (DRKS-ID: DRKS00011407).
Written informed consent was obtained for all patients.
For each patient a planning CT scan using a Toshiba
Aquillion LB CT Scanner (Toshiba Medical Systems
Corporation, Japan) was carried out and target delinea-
tion and treatment planning were performed. The clin-
ical target volume (CTVbreast/chestwall) encompassed the
chest wall or the glandular breast parenchyma. The
planning target volume (PTVbreast/chestwall) was obtained
by adding a 5 mm margin to the CTVbreast/chestwall. In
cases where a boost was applied, CTVboost included the
tumor bed, visible surgical clips and anatomical distor-
tion. The PTVboost was generated using a 5 mm iso-
tropic expansion on CTVboost. Patient set-up was in a
supine position on a positioning device (WingSTEP™,
IT-V, Austria) with both arms elevated above the head.
3D conformal radiation therapy was used. Treatment
planning was performed using the Oncentra 4.5.2 soft-
ware (Elekta AB, Stockholm, Sweden). All plans con-
sisted of two opposing tangential beams for the breast/
chest wall with the addition of some subfields to in-
crease dose homogeneity, as well as anterior/posterior
fields for regional nodal irradiation (RNI). RNI included
lymph node levels IV, III, Rotter lymph nodes and some
parts of lymph node level II according to the
ESTRO-guidelines. [16]
Before the first treatment fraction, patients were posi-
tioned using the skin marks and a laser-alignment-system
followed by the acquisition of iView™ portal images (Elekta
AB, Sweden) to verify proper positioning. Furthermore, a
surface reference image of the region of interest was ac-
quired using the Catalyst system after the patient had been
finally positioned.
Catalyst system
The Catalyst HD optical surface scanner manufactured
by C-RAD (Uppsala, Sweden) uses visible light to scan
the body surface using three cameras placed in
120-degree angles relative to each other. Figure 1 shows
the three Catalyst cameras beside the linear accelerator
(LINAC). The Catalyst system works through optical
surface imaging with LED light (blue: λ = 450 nm) and
reprojection captured by a CCD camera (green: λ =
528 nm; red: λ = 624 nm), which provides target position
control during treatment delivery. By the usage of three
cameras, measurements are performed based on optical
triangulation and a three-dimensional surface image of
the body is calculated and compared to an initial
reference image. The software calculates the relative
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displacement vectors in all three dimensions by using a
non-rigid body algorithm. [17]
The Catalyst camera system and the C-RAD
Catalyst-software tool c4D were utilized for real time ob-
servation of patients’ movements during every single RT
session. The system compares the real-time image with
a reference image and calculates absolute position devia-
tions from the surface-projected isocentre. The system’s
frame rate is approximately 200 frames per second and
the c4D-software calculates and outputs a mean value
over several samples.
According to the Catalyst system manual (2016
C-RAD Positioning AB) the system has a motion detec-
tion accuracy within 0,5 mm for a rigid body when the
couch is in a fixed position during treatment delivery,
which held always true in the present setting (3D plans
only). These data were verified using phantom measure-
ments in our department. As long as the view of the tar-
get was not restricted by any camera, a translational
accuracy of 1.17 ± 0.3 mm in the lateral and longitudinal
directions and 0.5 ± 0.2 mm in the vertical direction
were measured.
Data processing
Data retrieved from the software included time stamps,
cartesian coordinates including lateral, longitudinal and ver-
tical position deviations in millimeters, the deviation/mag-
nitude vector:
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
x2þy2þz2
p ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
lateral2þlongitudinal2þvertical2
p
,
rot-, roll- and pitch- angles as well as a boolean variable
that shows the beam status (on vs. off). Figure 2 shows a
screenshot of the c4D-tool.
All values were stored into a database and for every
treatment session the corresponding data sets were
exported from the c4D-software with a built-in function
into a *.skv-file. To extract the data from these files we
wrote a MATLAB script. All *.skv-data sets were imported
into the MATLAB workspace and a consistency check
was performed: whether data points were outliers or if a
table shift was performed during the treatment session. In
fact, all treatment sessions where portal images were
acquired were not evaluated to exclude confounding. In
cases of an observable table shift during an active Catalyst
recording session, the treatment session had to be
excluded from analysis. Additionally the motion results of
every single treatment session were manually checked for
plausibility in addition to an automatic outlier-
measurement.
Patient and tumour characteristics
The present study cohort included 104 patients with a
median age at diagnosis of 59 years (range: 27–86 years).
Tumour localization was mainly right-sided (65/104,
62.5%), as many patients presenting with left-side breast
cancer were treated using a DIBH technique, which was
an exclusion criterion for the present study. Most patients
had early stage breast cancer, classified pT1 (50/104, 48%)
or pT2 (36/104, 34.6%) with mainly negative nodal status
pN0 (69/104, 66.3%). Overall, 62 patients (59.6%) received
a conventional fractionated RT regimen to the breast or
chest wall, 17% received an additional irradiation of the
medial supraclavicular lymph nodes and 16% received a
sequential boost to the tumour bed. Moreover, 42 patients
(40.4%) received a hypofractionated treatment plan. 84.6%
of all patients had an adjuvant radiotherapy after a breast
conserving surgery, only 15.4% received a chest wall ir-
radiation after mastectomy. Table 1 gives an overview in-
cluding absolute and relative incidences for different
clinicopathological and radiotherapy parameters.
Statistical analyses
All data from the Catalyst software c4D were analyzed.
To find the maximum deviation during a treatment ses-
sion, we searched for the maximum deviation of the
deviation vector from the isocentre, as well as the max-
imum value along every single axis (lateral, longitudinal
and vertical). Results were further classified into two
subgroups, one group containing only measurements/
samples during beam-on time and the other group in-
cluding all measurements during the whole treatment
session from first beam-on to last beam-off, which was
defined as session time.
A t-test was used to evaluate whether the mean devia-
tions along the three axes were statistically significant
compared to zero. Additionally, for analyzing differences
in the distributions between the three different possible
directions (lateral, longitudinal and vertical) Friedman’s
test for coupled samples and a Bonferroni method as
post-hoc analysis were applied. Furthermore Mann-
Whitney-U-tests were used to compare independent
data samples.
Fig. 1 Image of the installed Catalyst™ system (showing the three
Catalyst cameras) at the Department of Radiation Oncology,
University Hospital, LMU Munich
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Correlation analysis between different parameters was
performed using Kendall rank correlation coefficient. A
robust trimmed two one-sided t-test (TOST) by Yuen
and Dixon (1973) was used for equivalence testing (pa-
rameters: α = 0.05, ε = 0.05, tr = 0.2). [18] As none of the
parameters in this study was normally distributed, in
order to reliable describe data distributions also add-
itional information including median, quantiles and
95%-confidence intervals are given. For all statistical
analyses a significance level of α = 0.05 was defined.
MATLAB Release 2016a (The MathWorks, Inc.,
Natick, Massachusetts, United States) was utilized for
data extraction as well as data processing and R 3.3.2
with libraries ggplot2, plot3D, R.matlab, equivalence for
statistical analyses.
Results
Descriptive analysis
Overall, 2028 treatment sessions during beam on time
as well as during the whole treatment session (including
the time during gantry movements) were evaluated. The
mean treatment session time was 154 s (standard
deviation [SD] = 53 s) (95%-confidence interval [CI]:
[79–268] seconds), and the mean beam-on time was 55
± 16 s (95%- CI: [31–90] seconds).
Table 2 shows mean, median and 95-CI of the max-
imum displacements during a treatment fraction on the
one hand (n = 2028 sessions), furthermore split into the
two subgroups. During beam-on time only the
maximum of the deviation vector was 1.93 ± 1.14 mm
(median = 1.63 mm) and 95%-CI [0.48–4.65] mm as
compared to 2.34 ± 1.40 mm (median = 2.03 mm) and
95%-CI [0.78–5.35] mm for the whole treatment session
time. Over 99% of the beam-on time, the magnitude of
the deviation vector was less than 4.45 mm.
As a further analysis in the second part of Table 2, all
samples were evaluated and reported for the two sub-
groups. In this case, the results between the two groups
were quite similar. The magnitude of the deviation vec-
tor during beam-on time was 1.12 ± 0.98 mm, the
Fig. 2 Screenshot of the c4D-software showing a patient surface image of a Catalyst scan (isocentre marked as point on the right chest wall);
below the image, the measurements during a treatment session are depicted over time. Bars indicate the magnitude of the deviation vector in
millimeter, and the bars above the time scale indicate the beam-status (on vs. off)
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median magnitude 0.78 mm (95%-CI: [0.11–3.77] mm).
The lateral deviation was in mean = 0.08 ± 0.65 mm,
median = 0.06 mm, 95%-CI: [− 1.24–1.48] mm, longitu-
dinal mean = 0.09 ± 0.81 mm, median = 0.04 mm,
95%-CI: [− 1.79–2.17] mm and vertical mean = 0.39 ±
0.98 mm, median = 0.36 mm, 95%-CI: [− 1.64–2.60] mm.
Figure 3 is a 3D-scatter plot of all samples during bea-
m-on time (for all patients and all fractions) in lat-
eral, longitudinal and vertical direction. It represents
an overview of how the data samples are distributed
in 3D-space. Additionally, the three histograms with
boxplots visualize the distributions along the three
axes. Figure 4 shows empirical cumulative distribution
functions for absolute isocentre deviations along the
three spatial axes and the deviation vector during
beam-on-time.
Analysis of distributions
For all three axes the results of t-tests analyzing the mean
deviations when compared to a value of zero were statisti-
cally significant (p < 0.01), which means that there is a
drift of the isocentre during treatment along all axes
significantly larger than zero. Friedmans rank analysis for
coupled samples for maximum displacement during
beam-on time resulted in a significant difference of the
distributions along the three axes (Chi-square(2) = 470.53,
p < 0.01, n = 2028). Post-hoc Dunn-Bonferroni-Tests did
not show a distribution similarity between any two of the
three directions.
Mann-Whitney-U-tests for the irradiation side (left vs.
right) did not show any significant difference in the
maximum deviation (p = 0.85), also there was no
difference between breast and thoracic wall irradiation
(p = 0.92).
Correlation analysis
Correlation analysis showed a weak correlation between
maximum magnitude of deviation and time of treatment
session (Kendall-Tau = 0.082, p < 0.01). Furthermore, be-
tween vertical and longitudinal (Kendall-Tau = 0.362, p <
0.01) deviation, as well as between vertical and lateral
Table 2 Descriptive analysis of displacements along the axes divided into maximum displacement during a treatment session, and
all samples of a treatment session. Furthermore, the observation results are split into samples during beam-on time only and the
whole treatment session time (n = 104 patients, sessions = 2028)
Beam on time only Whole treatment session time
Maximum displacement
per session
(N = 2028)
Mean ± Standard
deviation [mm]
Median [mm] 95%-CI [mm] Mean ± Standard
deviation [mm]
Median [mm] 95%-CI [mm]
Lateral 0.18 ± 1.06 0.38 [−1.88–2.1] −0.04 ± 1.39 −0.25 [−2.67–2.3]
Longitudinal 0.17 ± 1.32 0.34 [−2.89–3.11] 0.10 ± 1.71 0.45 [−3.36–3.23]
Vertical 0.68 ± 1.53 0.84 [−2.9–3.55] 0.70 ± 1.87 1.07 [− 3.62–3.74]
Magnitude of deviation-vector 1.93 ± 1.14 1.63 [0.48–4.65] 2.34 ± 1.40 2.03 [0.78–5.35]
All samples per session
Lateral 0.08 ± 0.65 0.06 [−1.24–1.48] 0.07 ± 0.67 0.06 [−1.32–1.49]
Longitudinal 0.09 ± 0.81 0.04 [− 1.79–2.17] 0.10 ± 0.84 0.05 [−1.78–2.15]
Vertical 0.39 ± 0.98 0.36 [− 1.64–2.60] 0.43 ± 1.03 0.40 [−1.79–2.67]
Magnitude of deviation-vector 1.12 ± 0.98 0.78 [0.11–3.77] 1.19 ± 0.99 0.88 [0.13–3.8]
Table 1 Descriptive patient characteristics and radiotherapy
parameters of the study cohort (n = 104)
No. (%)
Age at diagnosis (yrs.)
mean ± SD 59.7 ± 13.3 years
median (range) 59.0 (50.0–70.0) years
Tumour localisation
left 39 (37.5%)
right 65 (62.5%)
Tumour stage
pTis 10 (9.6%)
pT1 50 (48%)
pT2 36 (34.6%)
pT3 4 (3.8%)
pT4 4 (3.8%)
Nodal status
pN0 69 (66.3%)
pN1 22 (21.2%)
pN2 9 (8.7%)
pNx 4 (3.8%)
Fractionation
Normo-fractionated (2/50 Gy) 62 (59.6%)
Hypo-fractionated (2.67/40 Gy) 42 (40.4%)
Radiotherapy
Whole-Breast 88 (84.6%)
Chest-wall 16 (15.4%)
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(Kendall-Tau = − 0.031, p = 0.04) deviation a significant
correlation was verified.
Two one sided t-test for equivalence
TOST for equivalence between beam-on time only
and the whole session time of maximum displacement
for all three directions was not significant (p > 0.05).
This has to be interpreted as a dissimilarity of values,
with larger variations during beam-off time, for ex-
ample during gantry movement. By looking at all
samples, for the lateral and longitudinal direction a
similarity was verified (p < 0.01) between beam-on
time only and the whole session time, but not for the
vertical direction (p = 0.06).
Discussion
The present study faces the issue of quality assurance
during breast irradiation: for this aim, intra-fractional
monitoring of the patients’ surface was evaluated using
an optical non-invasive method. Moreover, to our know-
ledge, the present experience reports and discusses the
data of the largest patient population (104 patients and
over 2000 treatment sessions) in the setting of
intra-fractional motion management by using an optical
Fig. 3 3D - scatter plot showing deviation around the isocentre including all patients and all fractions during the beam-on time (vertical
deviation in color); additional histograms and boxplots for lateral, longitudinal and vertical axes (N = 104 patients, 69,654 points)
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surface imaging system for breast cancer RT. Since the
maximum single deviation during treatment delivery
may be interpreted as a “worst case” deviation during a
single treatment session and could influence adequate
coverage within the applied setup margins (5 mm CTV
to PTV), we have analyzed them separately from all the
other samples recorded during every treatment session.
During beam-on time only a maximum deviation
(magnitude of vector calculated as shown in Fig. 4) of
mean 1.93 ± 1.14 mm (95%-CI: 0.48–4.65 mm) was
found. Along the lateral axis the deviations were smaller
(95%-CI: -1.88 – 2.1 mm) than on the longitudinal
(95%-CI: -2.89 – 3.11 mm) or vertical (95%-CI: -2.9 –
3.55 mm) axis. Therefore, we were able to show in the
present study that even this “worst case” momentary de-
viation was within the limits of applied setup margins,
while most of the time, deviations were abundantly
within the PTV margins. In fact, all samples during
beam-on time, reported a lateral deviation of mean 0.08
± 0.65 mm, longitudinal mean 0.09 ± 0.81 mm and verti-
cal mean 0.39 ± 0.98 mm. The cumulative distribution
functions for the spatial axes and the deviation vector
(Fig. 4) gives an overview of the deviation distribution.
Various techniques for intra-fractional motion analysis
in breast irradiation are reported and discussed in
literature. X-ray imaging as described by Hirata et al.
represents one of the options. [19] The authors used or-
thogonal X-ray imaging on 23 patients before and after a
treatment session to observe internal target motions
referring to surgical clips displacements in accelerated
partial breast irradiation. The magnitude of intra-frac-
tional motion was depending on the direction, e.g. it
showed a systemic baseline drift of 1.5 mm in the pos-
terior direction but also depending on patients’ charac-
teristics and tumour cavity location. Yue et al. pursued a
similar approach by comparing marker- and bone-based
matching resulting in an average intra-fractional motion
magnitude of 4.2 mm vs. 2.6 mm. [20] Later, Yue et al.
described tumour side dependent directional motion
along the lateral axis between left- and right-sided breast
cancer patients. [21]
Other authors applied continuous portal imaging with
a sample frequency of 7.5 Hz during the delivery of two
tangential fields in free-breathing modality on breast
cancer patients. The amplitude of the intra-fractional
chest wall motion had a mean value of 2.0 ± 0.7 mm and
a maximum value of 8 mm. [22] The main disadvantages
of X-ray imaging in motion analysis are represented by
the additional radiation exposure and the restriction to
bone- or marker-based matching strategies. Especially in
the case of bone-matching, results may differ from the
actual tissue movement. Nevertheless, the obtained
results remained within 1 cm in any direction and there-
fore comparable to the results of the experience reported
in the present study.
Another strategy was applied by the group of Kinoshita
et al., who positioned a gold marker near the nipple on
the skin of breast cancer patients and used a fluoroscopic
real-time tracking system for monitoring. Baseline shift
and range of motion stayed within a few millimeters. [23]
An optical approach method to measure intra-fractional
motions was recently reported by Ricotti et al. [12], who
used an optical system with infrared reflective surface
markers for motion tracking. Based on their high sample
frequency, the investigators were able to divide the motion
into a baseline drift and respiratory-caused changes.
Measurements were quite time-consuming because a cali-
bration before every session was required and patients
needed several surface markers positioned on their chest
wall. In contrast, in our here reported experience, no
Fig. 4 a empirical cumulative distribution functions for absolute isocentre deviations in millimeters along the three spatial axes and the deviation
vector during beam-on-time; b empirical cumulative distribution functions for maximum absolute isocentre deviations; horizontal dashed black
lines mark lower [0.025] and upper bound [0.975] of 95%-confidence interval
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additional markers were required. However, the findings re-
ported by Ricotti and colleagues seem to be comparable to
our analyses; the authors calculated a baseline drift of 0 ±
1.1 mm in the lateral direction, − 0.5 ± 1.7 mm in the longi-
tudinal and − 1.4 ± 1.8 mm in the vertical direction. [12]
Regarding the influence of duration of the RT session,
Wiant et al. analyzed data of 33 patients during 831
monitoring sessions. Most patients stayed within a
5 mm drift range. [24] However, the authors reported a
strong correlation between patient drift and duration of
treatment session. It is noteworthy that in contrast to
the present study, the mean observation time was nearly
twice as long (mean 342 s vs. 154 s). This underlines the
fact, that treatment duration might strongly influence
intra-fractional baseline drifts. Similarly, Jensen et al.
used a self-developed laser-system for measuring dis-
placements along the anterior-posterior (AP)-direction
for intrafraction motion in breast cancer RT, showing a
baseline drift in the posterior direction of − 1.3 mm at
the end of the treatment session. Approximately 4% of
treatments had a larger baseline drift than 5 mm at
5 min. [25] In our series, the mean treatment session
time was very short with 154 s (95%CI: 79–268 s), thus
resulting in a very weak correlation between duration of
RT session and the maximum deviation of displacement.
As a more modern approach, Acharya et al. analyzed
intra-fractional motion using magnetic resonance im-
aging (MR) guided-IMRT and calculated an intra-frac-
tional tumour bed cavity displacement of about 0.6 ±
0.4 mm along the longitudinal and vertical axis. According
to their results, the mean difference between planned and
delivered dose was within 1 %. [26] Similarly, another
group used MRI with two time scales (2D and 3D MRI)
showing a median deviation of about 2 vs. 2.2 mm. [27]
MR-imaging during RT represents an elegant and promis-
ing approach to track target volumes in real time, espe-
cially in soft tissues including breast. Nevertheless,
compared to other here described optical tracking sys-
tems, these image guided systems still remain very expen-
sive and currently not widely available in clinical practice.
One of the limitations of the present study is repre-
sented by the increased deviation vectors during gantry
rotation. At certain angles, the gantry can mask one or
two of the three cameras of the Catalyst system, causing
misleading measurement outputs. This situation can be
observed in higher deviation values during the whole
treatment session time as compared to the results of the
beam-on time only (see Table 2). Nevertheless, consider-
ing that only patients receiving 3D conformal RT, with a
fixed gantry position during beam-on time, were re-
cruited in the present study, this technical issue can be
estimated of minor relevance for the present analysis.
In summary, intra-fraction motion during 2028 ses-
sions of breast cancer RT observed in the present study
was maintained within 5 mm in any direction as the
confidence intervals show. Although specific advices on
the size of PTV margins are not provided by current
guidelines (since they should be based on actual mea-
surements of set-up performance), the here reported de-
viations are within the clinically most common standard
PTV-setup margins of 5 mm. [16] One further aspect of
implications of the present findings for treatment plan-
ning could be the skin flashing of treatment fields in
breast IMRT. Intensity extension with the help of
auto-flash tools usually aims to account for intra-frac-
tional patient motion or set-up errors. Based on the
present results, typically used margins of up to 2.5 cm
could be substantially reduced. [28]
Conclusion
Due to the large number of data analyzed (2028 sessions
in 104 patients) and the detailed reported results of
specific deviations (< 5 mm), the optical real-time sur-
face imaging system utilized in the present study showed
to be an important tool for intra-fraction motion man-
agement in breast cancer RT. Not less important, the
here discussed surface imaging system with visible light
represents the peculiarity to be absolutely safe for
patients, as it is a non-invasive approach to monitor
patients position in real time without any additional ra-
diation exposure.
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